Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum91930Research ArticleEtiologicheskie aspekty terapii khronicheskikh pankreatitovMinushkinO. N-MaslovskiyL. V-150620057644444728122021Copyright © 2005, Consilium Medicum2005[Smith M.D, Pawlak M, Pantanowitz D.P. Hyperparathyroidism and chronic pancreatitis. S Afr Surg 1999 Feb; 37 (1): 12–4.][Yadav D, Pitchmoni C.S. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol 2003 Jan; 36 (1): 54–62.][Henzen C, Rock M, Schnieper C. Heparin and insulin in the treatment of acute hypertriglycerdemia - induced pancreatitis. Schweiz Med Wochenschr 1999 Sep 4; 129 (35): 1242–8.][Marrota P.G, Gregor J.C, Taves D.T. Can J Gastroenterol 1996, 10: 385–8.][Chebli J.M, Ferrari J.A.P, Silva M.R et al. Biliary microcrystals in idiopathic acute pancreatitis: clue for occult underlying biliary etiology. Arq Gastoenterol 2000 Apr-Jun; 37 (2): 93–101.][Testoni P.A, Caporuscio S, Bagnolo F, Lella F. Idiopathic recurrent pancreatitis: long - term results after ERCP, endoscopic sphincterotomy, or ursodeoxycholic acid treatment. Am J Gastroenterol.][Whitcomb D.C, Somogyi l. Lessons from hereditary pancreatitis. Croat Med J 2001 Aug; 42 (4): 484–7.][Hong S.P, Park S.W, Chung J.P et al. Autoimmune pancreatitis with effective steroid therapy. Yonsei Med J 2003 Jun 30; 44 (3): 534–8.][Коротько Г.Ф. Секреция поджелудочной железы. 2003; 223 с.][Ревтович М.Ю. Вариант неспецифической антицитокиновой терапии деструктивных форм острого панкреатита. Белорус. мед. журн. 2003; 3.][Леонович С.И. и др. Влияние октреотида на перекисное окисление липидов у больных острым панкреатитом. Рецепт. 2003; 3.][Andriulli A, Leandro G, Clemente R et al. Meta - analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther 1998 Mar; 12 (3): 237–45.][Uhl W, Buchler M.W, Malfertheiner P et al. A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut 1999 Jul; 45 (1): 97–104.][Toskes P.P. Update on diagnosis and management of chronic pancreatitis. Curr Gastroenterol Rep 1999; 1 (2): 145–53.][Paran H, Mayo A, Paran D et al. Octreotide treatment in patients with severe acute pancreatitis. Dig Dis Sci 2000; 45 (11): 2247–51.][Li-Ling J, Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br J Surg 2001; 88 (2): 190–9.][Nicou G.C et al. The Significance of the dosage adjustment of octreotide in the treatment of acute pancreatitis of moderate severity. Hepatogastroenterol 2001; 48 (42): 1754–7.][Karakoyunlar O et al. High dose octreotide in the management of acute pancreatitis. Hepatogastroenterol 1999; 46 (27): 1968–72.]